Impaired Autophagy and Mitochondrial Dynamics Are Involved in Sorafenib-Induced Cardiomyocyte Apoptosis

Sorafenib (Sor), a novel multi-target Anticancer drug also induces severe toxicity in heart, while the mechanism of its cardiotoxicity remains to be fully elucidated. Dysregulation of Autophagy and mitochondrial dynamics imbalance have been implicated in cardiomyocyte death. The aim of this study is to test the hypothesis that Sor disrupts Autophagy and mitochondrial dynamics, thereby aggravating Sor-induced oxidative stress damage to cardiomyocytes. Our results revealed that Sor (≥ 5μM) concentration- and time-dependently reduced cell viability and induced Apoptosis in H9c2 myoblasts. Sor treatment promoted intracellular Reactive Oxygen Species (ROS) generation, and subsequent CA²⁺ overload as well as Apoptosis, which were abolished by the ROS scavenger MPG. Sor inhibited the basal Autophagy activity of cells, as supported by the fact that ERK1/2 inhibition-dependent decreases of autophagosomes and autolysosomes, and p62 accumulation in a concentration- and time-dependent manner. Improving Autophagy with rapamycin abrogated Sor-induced ROS and CA²⁺ overloads, and cell Apoptosis. Furthermore, Sor compromised mitochondrial morphology and caused excessive mitochondrial fragmentation in cells. The imbalance of mitochondrial dynamics was attributed to ROS-mediated CaMKII overactivity, and increased phosphorylation of dynamin-related protein 1 (phosph-Drp1). Suppression of CaMKII with KN-93 or mitochondrial fission with mitochondrial division inhibitor-1 (Mdivi-1) attenuated Sor-induced ROS and CA²⁺ overloads as well as Apoptosis. In conclusion, these results provide the first evidence that impairments in Autophagy and mitochondrial dynamics are involved in Sor-induced cardiomyocyte Apoptosis. The present study may provide a potential strategy for preventing or reducing cardiotoxicity of Sor.